Summary
CVS Health's 2017 10-K filing reflects a company in transition, marked by significant strategic initiatives and a focus on expanding its healthcare services. The company's performance in 2017 was influenced by a complex operating environment, including competitive pressures in the pharmacy benefit manager (PBM) and retail pharmacy sectors. Despite these challenges, CVS Health demonstrated resilience, with revenues primarily driven by its PBM segment and retail pharmacy operations. The acquisition of Aetna, announced in late 2017 and pending completion, represents a transformative step, aiming to create a more integrated healthcare offering and unlock significant synergies. Investors should pay close attention to the integration of Aetna and the potential impact on CVS Health's future growth trajectory and competitive positioning.
Financial Highlights
60 data points| Revenue | $184.79B |
| Cost of Revenue | $156.22B |
| Gross Profit | $28.55B |
| Operating Expenses | $18.81B |
| Operating Income | $9.54B |
| Interest Expense | $1.06B |
| Net Income | $6.62B |
| EPS (Basic) | $6.47 |
| EPS (Diluted) | $6.44 |
| Shares Outstanding (Basic) | 1.02B |
| Shares Outstanding (Diluted) | 1.02B |
Key Highlights
- 1The company generated total revenues of $184.7 billion in 2017, a slight increase from the prior year, primarily driven by the PBM segment.
- 2Net income attributable to CVS Health was $3.0 billion, or $2.95 per diluted share, compared to $4.9 billion, or $4.70 per diluted share in 2016, reflecting an impact from the adoption of new accounting standards and increased operating costs.
- 3The Retail Pharmacy segment continued to face challenges, with comparable store sales declining slightly due to lower prescription volumes and front-of-store sales.
- 4The Pharmacy Benefit Management (PBM) segment, through CVS Caremark, remained a significant revenue and profit driver, benefiting from strong PBM service revenues.
- 5Significant strategic development: In December 2017, CVS Health announced its intention to acquire Aetna Inc., a major health insurance provider, a deal valued at approximately $69 billion.
- 6The company continued its share repurchase program, returning capital to shareholders, while also managing its debt levels.
- 7Risk factors highlighted include intense competition, regulatory changes affecting healthcare and pharmacy benefits, and the successful integration of potential future acquisitions.